Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study

OBJECTIVES: New targets and approaches are under investigation for the treatment of nonmuscle invasive bladder cancer (NMIBC). Preclinical data suggest cyclooxygenase-2 (COX-2) as a promising target. Celecoxib, a COX-2 selective inhibitor, inhibits tumor development and enhances survival, both in vi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Urol
Main Authors: Pagliarulo, Vincenzo, Ancona, Patrizia, Martines, Ivan, Spadavecchia, Rossana, Di Stasi, Savino, Alba, Stefano, Cormio, Luigi, Fanizza, Caterina, Salerno, Annamaria, Carrieri, Giuseppe, Pagliarulo, Arcangelo
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2015
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647141/
https://ncbi.nlm.nih.gov/pubmed/26622316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215599695
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares